Literature DB >> 24509883

Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation.

Kosuke Endo1, Taku Iida, Shintaro Yagi, Atsushi Yoshizawa, Yasuhiro Fujimoto, Kohei Ogawa, Yasuhiro Ogura, Akira Mori, Toshimi Kaido, Shinji Uemoto.   

Abstract

PURPOSE: Uncontrollable hepatic hydrothorax and massive ascites (H&MA) requiring preoperative drainage are sometimes encountered in liver transplantation (LT). We retrospectively analyzed the characteristics of such patients and the impact of H&MA on the postoperative course.
METHODS: We evaluated 237 adult patients who underwent LT in our institute between April 2006 and October 2010.
RESULTS: Recipients with uncontrollable H&MA (group HA: n = 36) had more intraoperative bleeding, higher Child-Pugh scores, lower serum albumin concentrations and higher blood urea nitrogen concentrations than those without uncontrollable H&MA (group C: n = 201). They were also more likely to have preoperative hepatorenal syndrome and infections. The incidence of postoperative bacteremia was higher (55.6 vs. 46.7%, P = 0.008) and the 1- and 3-year survival rates were lower (1 year: 58.9 vs. 82.9%; 3 years: 58.9 vs. 77.7%; P = 0.003) in group HA than in group C. The multivariate proportional regression analyses revealed that uncontrollable H&MA and the Child-Pugh score were independent risk factors for the postoperative prognosis.
CONCLUSIONS: Postoperative infection control may be an important means of improving the outcome for patients with uncontrollable H&MA undergoing LT, and clinicians should strive to perform surgery before H&MA becomes uncontrollable.

Entities:  

Mesh:

Year:  2014        PMID: 24509883     DOI: 10.1007/s00595-014-0839-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

Review 1.  Hepatorenal syndrome.

Authors:  P Ginès; V Arroyo
Journal:  J Am Soc Nephrol       Date:  1999-08       Impact factor: 10.121

Review 2.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

3.  The North American Study for the Treatment of Refractory Ascites.

Authors:  Arun J Sanyal; Chris Genning; K Rajender Reddy; Florence Wong; Kris V Kowdley; Kent Benner; Timothy McCashland
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

4.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

5.  Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.

Authors:  Ma Somsouk; Rachel Kornfield; Eric Vittinghoff; John M Inadomi; Scott W Biggins
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

6.  Management of adult patients with ascites due to cirrhosis: an update.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

7.  The long-term outcomes of patients with hepatocellular carcinoma after living donor liver transplantation: a comparison of right and left lobe grafts.

Authors:  Akinobu Taketomi; Ken Shirabe; Takeo Toshima; Kazutoyo Morita; Naotaka Hashimoto; Hiroto Kayashima; Tohru Ikegami; Tomoharu Yoshizumi; Yuji Soejima; Yoshihko Maehara
Journal:  Surg Today       Date:  2012-01-14       Impact factor: 2.549

8.  Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.

Authors:  Francesco Salerno; Manuela Merli; Oliviero Riggio; Massimo Cazzaniga; Valentina Valeriano; Massimo Pozzi; Antonio Nicolini; Filippo Salvatori
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

9.  Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Authors:  Paul H Hayashi; Lisa Forman; Tracy Steinberg; Thomas Bak; Michael Wachs; Marcelo Kugelmas; Gregory T Everson; Igal Kam; James F Trotter
Journal:  Liver Transpl       Date:  2003-07       Impact factor: 5.799

10.  Paracentesis of ascitic fluid. A safe procedure.

Authors:  B A Runyon
Journal:  Arch Intern Med       Date:  1986-11
View more
  1 in total

Review 1.  Pulmonary complications of hepatic diseases.

Authors:  Salim R Surani; Yamely Mendez; Humayun Anjum; Joseph Varon
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.